Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 26, 2024   107,357,000      
Beginning balance at Dec. 26, 2024 $ 2,170,158 $ 107 $ 547,818 $ (40) $ 1,622,273
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 6,580   6,580    
Exercise of stock options (in shares)   50,000      
Exercise of stock options 1,288   1,288    
Issuance of common stock upon vesting of restricted stock units (in shares)   247,000      
Issuance of common stock upon vesting of restricted stock units 0 $ 1 (1)    
Shares issued under employee stock purchase plan (in shares)   36,000      
Shares issued under employee stock purchase plan 3,081   3,081    
Common stock redeemed for tax liability (in shares)   (84,000)      
Common stock redeemed for tax liability (8,212)   (8,212)    
Other comprehensive gain (loss), net of tax (10)     (10)  
Net income 48,878       48,878
Ending balance (in shares) at Mar. 27, 2025   107,606,000      
Ending balance at Mar. 27, 2025 $ 2,221,763 $ 108 550,554 (50) 1,671,151
Beginning balance (in shares) at Dec. 25, 2025 107,774,329 107,774,000      
Beginning balance at Dec. 25, 2025 $ 2,408,836 $ 108 577,786 22 1,830,920
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense $ 8,369   8,369    
Exercise of stock options (in shares) 100,471 100,000      
Exercise of stock options $ 2,534   2,534    
Issuance of common stock upon vesting of restricted stock units (in shares)   248,000      
Shares issued under employee stock purchase plan (in shares)   53,000      
Shares issued under employee stock purchase plan 2,882   2,882    
Common stock redeemed for tax liability (in shares)   (81,000)      
Common stock redeemed for tax liability (5,618)   (5,618)    
Other comprehensive gain (loss), net of tax 25     25  
Net income $ 39,709       39,709
Ending balance (in shares) at Mar. 26, 2026 108,094,150 108,094,000      
Ending balance at Mar. 26, 2026 $ 2,456,737 $ 108 $ 585,953 $ 47 $ 1,870,629